These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23976844)

  • 1. Valproic acid-associated low fibrinogen and delayed intracranial hemorrhage: case report and mini literature review.
    Chen HF; Xu LP; Luo ZY; Yu ZQ; Li ZY; Cui QY; Qin LM; Ren YY; Shen HS; Tang JQ; Jin LJ; Zhu JJ; Wang J; Wang KY; Wu TQ; Wang ZY
    Drug Des Devel Ther; 2013; 7():767-70. PubMed ID: 23976844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudo valproate-induced hypofibrinogenemia.
    Breningstall GN; Cich JA
    Pediatr Neurol; 1996 May; 14(4):345. PubMed ID: 8962595
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypofibrinogenemia and intracranial hemorrhage induced by valproic acid: a case report].
    Chen HF; Li ZY; Tang JQ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):682. PubMed ID: 23134874
    [No Abstract]   [Full Text] [Related]  

  • 4. [Three cases of hypofibrinogenemia induced by chemotherapy with a combination of synthetic ACTH and valproic acid].
    Tokuda K; Kodani N; Ogino T
    No To Hattatsu; 1994 Jan; 26(1):50-6. PubMed ID: 8280448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapidly progressive Kaposi's Sarcoma in an Iraqi boy received Valproic acid: a case report and review of literature.
    Al-Kzayer LF; Keizer P; Abdulraheem FT; Sano K; Kamata M; Sakashita K; Habbaba LA; Koike K
    BMC Pediatr; 2016 Jul; 16():111. PubMed ID: 27459853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of valproic acid on blood loss in patients with cerebral palsy.
    Chambers HG; Weinstein CH; Mubarak SJ; Wenger DR; Silva PD
    J Pediatr Orthop; 1999; 19(6):792-5. PubMed ID: 10573351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hemorrhagic pancreatitis due to the use of valproic acid in a child.
    Ozaydin E; Yükselgüngör H; Köse G
    Eur J Paediatr Neurol; 2008 Mar; 12(2):141-3. PubMed ID: 17881258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic Acid-Induced Coagulopathy.
    Kumar R; Vidaurre J; Gedela S
    Pediatr Neurol; 2019 Sep; 98():25-30. PubMed ID: 31201069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible dementia and gait disturbance after prolonged use of valproic acid.
    Evans MD; Shinar R; Yaari R
    Seizure; 2011 Jul; 20(6):509-11. PubMed ID: 21435910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
    Mink S; Muroi C; Seule M; Bjeljac M; Keller E
    Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are post intracerebral hemorrhage seizures prevented by anti-epileptic treatment?
    Gilad R; Boaz M; Dabby R; Sadeh M; Lampl Y
    Epilepsy Res; 2011 Aug; 95(3):227-31. PubMed ID: 21632213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein C deficiency related to valproic acid therapy: a possible association with childhood stroke.
    Gruppo R; Degrauw A; Fogelson H; Glauser T; Balasa V; Gartside P
    J Pediatr; 2000 Nov; 137(5):714-8. PubMed ID: 11060540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is operative blood loss associated with valproic acid? Analysis of bilateral femoral osteotomy in children with total involvement cerebral palsy.
    Carney BT; Minter CL
    J Pediatr Orthop; 2005; 25(3):283-5. PubMed ID: 15832138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
    Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
    Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate-induced reversible sensorineural hearing loss: a case report with serial audiometry and pharmacokinetic modelling during a valproate rechallenge.
    Yeap LL; Lim KS; Lo YL; Bakar MZ; Tan CT
    Epileptic Disord; 2014 Sep; 16(3):375-9. PubMed ID: 25167568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the toxicity of valproic-acid.
    Moreiras Plaza M; Rodríguez Goyanes G; Cuiña L; Alonso R
    Clin Nephrol; 1999 Mar; 51(3):187-9. PubMed ID: 10099893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cool side effect of valproic acid administration: Single dose-induced hypothermia.
    Servati N; Priano J; Vilar J; Schiel J
    Am J Emerg Med; 2018 Nov; 36(11):2129.e3-2129.e4. PubMed ID: 30060964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence seizures aggravated by valproic acid.
    Lerman-Sagie T; Watemberg N; Kramer U; Shahar E; Lerman P
    Epilepsia; 2001 Jul; 42(7):941-3. PubMed ID: 11488896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative valproate administration does not increase blood loss during temporal lobectomy.
    Ward MM; Barbaro NM; Laxer KD; Rampil IJ
    Epilepsia; 1996 Jan; 37(1):98-101. PubMed ID: 8603633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hallucinations after withdrawal of valproic acid.
    de Laat SA; Hillegers MH; Jansen FE; Braun KP; de Graeff-Meeder ER
    Pediatrics; 2012 Jul; 130(1):e236-8. PubMed ID: 22689876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.